Loading…

Bleomycin-Induced Fibrosis and the Effectiveness of Centella Asiatica as a Treatment

Plant treatment has been used for thousands of years and has been proven to treat acute and chronic diseases. The function of the traditional plant is as an antimicrobial agent, anticancer, antioxidant, and therapeutic gene in healing wounds and inflammation. Lung fibrosis caused by bleomycin can de...

Full description

Saved in:
Bibliographic Details
Published in:Journal of experimental pharmacology 2024-09, Vol.16, p.311-320
Main Authors: Soeroso, Noni Novisari, Ichwan, Muhammad, Wahyuni, Arlinda Sari, Mariedina, Causa Trisna, Pakpahan, Yabestin Alfrianus
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c3129-17df2f7216c66cd75c47354365fd4927e2eaa875d515dda35b8e55be8585448a3
container_end_page 320
container_issue
container_start_page 311
container_title Journal of experimental pharmacology
container_volume 16
creator Soeroso, Noni Novisari
Ichwan, Muhammad
Wahyuni, Arlinda Sari
Mariedina, Causa Trisna
Pakpahan, Yabestin Alfrianus
description Plant treatment has been used for thousands of years and has been proven to treat acute and chronic diseases. The function of the traditional plant is as an antimicrobial agent, anticancer, antioxidant, and therapeutic gene in healing wounds and inflammation. Lung fibrosis caused by bleomycin can develop into chronic lung disease, which ends in tissue death if not treated immediately. The purpose of this study is to predict and explain the impact of extract on model rats exposed to bleomycin in their lungs as a treatment or anti-fibrinolysis. This research is an analytical study with a randomized in-vivo experimental design divided into 3 groups of 5 male Wistar rats aged 10 weeks. Negative control group (K) with intratracheal induction of bleomycin alone. The positive group was given intratracheal bleomycin 4 mg/kg/BB on days 0 and 21 and added induction at 400 mg (P1) on days 15 to 49. The other positive group was given intratracheal bleomycin 4 mg/kg/BB on days 0 and 21 and added induction at 800 mg (P2) on days 15 to 49. Data were collected according to findings of lung histology analysis of rat samples. In the interalveolar septum group, there was a difference in Masson's Trichrome staining results in groups K and P1 with p0.05). The induction of bleomycin 4 mg/kg/BB was proven to cause fibrosis in the lungs of rats, and extract was used as a treatment. Therefore, further research regarding antifibrotic drugs is hoped to reduce fibrotic areas significantly.
doi_str_mv 10.2147/JEP.S463899
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_71ddcfc62ffe42ba82353a678da9ab4e</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A815289565</galeid><doaj_id>oai_doaj_org_article_71ddcfc62ffe42ba82353a678da9ab4e</doaj_id><sourcerecordid>A815289565</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3129-17df2f7216c66cd75c47354365fd4927e2eaa875d515dda35b8e55be8585448a3</originalsourceid><addsrcrecordid>eNptkt-LEzEQxxdRvOO8J99lQRBBWptfm-RJaulp5UDB-hxmk0mbYzc5N9uD--9NbT1aMHlImHzmy8zkW1WvyWxKCZcfvy1_TH_yhimtn1WXhEg9IVzw5yf3i-o657tZWUxrKfjL6oJpxoXU-rJaf-4w9Y82xMkqup1FV9-Edkg55Bqiq8ct1kvv0Y7hASPmXCdfLzCO2HVQz3OAMVioodD1ekAY-_L2qnrhoct4fTyvql83y_Xi6-T2-5fVYn47sYzQUpx0nnpJSWObxjopLJdMcNYI77imEikCKCmcIMI5YKJVKESLSijBuQJ2Va0Oui7BnbkfQg_Do0kQzN9AGjYGhlJfh0YS56y3DS29cNqCokwwaKRyoKHlWLQ-HbTud22PzpY2BujORM9fYtiaTXowhHCmuNBF4f1RYUi_d5hH04ds93OKmHbZMEIInQmqRUHfHtANlNpC9KlI2j1u5ooIqrRo9tT0P1TZDvtgU0QfSvws4d1JwhahG7c5dbsxpJjPwQ8H0JafzgP6pz7JzOx9ZYqvzNFXhX5zOpon9p-L2B9yuMYn</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3111205295</pqid></control><display><type>article</type><title>Bleomycin-Induced Fibrosis and the Effectiveness of Centella Asiatica as a Treatment</title><source>Taylor &amp; Francis Open Access</source><source>Publicly Available Content (ProQuest)</source><source>PubMed Central</source><creator>Soeroso, Noni Novisari ; Ichwan, Muhammad ; Wahyuni, Arlinda Sari ; Mariedina, Causa Trisna ; Pakpahan, Yabestin Alfrianus</creator><creatorcontrib>Soeroso, Noni Novisari ; Ichwan, Muhammad ; Wahyuni, Arlinda Sari ; Mariedina, Causa Trisna ; Pakpahan, Yabestin Alfrianus</creatorcontrib><description>Plant treatment has been used for thousands of years and has been proven to treat acute and chronic diseases. The function of the traditional plant is as an antimicrobial agent, anticancer, antioxidant, and therapeutic gene in healing wounds and inflammation. Lung fibrosis caused by bleomycin can develop into chronic lung disease, which ends in tissue death if not treated immediately. The purpose of this study is to predict and explain the impact of extract on model rats exposed to bleomycin in their lungs as a treatment or anti-fibrinolysis. This research is an analytical study with a randomized in-vivo experimental design divided into 3 groups of 5 male Wistar rats aged 10 weeks. Negative control group (K) with intratracheal induction of bleomycin alone. The positive group was given intratracheal bleomycin 4 mg/kg/BB on days 0 and 21 and added induction at 400 mg (P1) on days 15 to 49. The other positive group was given intratracheal bleomycin 4 mg/kg/BB on days 0 and 21 and added induction at 800 mg (P2) on days 15 to 49. Data were collected according to findings of lung histology analysis of rat samples. In the interalveolar septum group, there was a difference in Masson's Trichrome staining results in groups K and P1 with p&lt;0.05 (p=0.036). However, there was no difference in histopathological staining results in groups K and P2 (p&gt;0.05). The induction of bleomycin 4 mg/kg/BB was proven to cause fibrosis in the lungs of rats, and extract was used as a treatment. Therefore, further research regarding antifibrotic drugs is hoped to reduce fibrotic areas significantly.</description><identifier>ISSN: 1179-1454</identifier><identifier>EISSN: 1179-1454</identifier><identifier>DOI: 10.2147/JEP.S463899</identifier><identifier>PMID: 39345799</identifier><language>eng</language><publisher>New Zealand: Dove Medical Press Limited</publisher><subject>Bleomycin ; Cancer ; Care and treatment ; centella asiatica ; Chronic diseases ; Development and progression ; Fibrosis ; Lung diseases ; Original Research ; pulmonary fibrosis ; treatment</subject><ispartof>Journal of experimental pharmacology, 2024-09, Vol.16, p.311-320</ispartof><rights>2024 Soeroso et al.</rights><rights>COPYRIGHT 2024 Dove Medical Press Limited</rights><rights>2024 Soeroso et al. 2024 Soeroso et al.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3129-17df2f7216c66cd75c47354365fd4927e2eaa875d515dda35b8e55be8585448a3</cites><orcidid>0000-0002-2687-4924</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11438459/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11438459/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,36992,53770,53772</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39345799$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Soeroso, Noni Novisari</creatorcontrib><creatorcontrib>Ichwan, Muhammad</creatorcontrib><creatorcontrib>Wahyuni, Arlinda Sari</creatorcontrib><creatorcontrib>Mariedina, Causa Trisna</creatorcontrib><creatorcontrib>Pakpahan, Yabestin Alfrianus</creatorcontrib><title>Bleomycin-Induced Fibrosis and the Effectiveness of Centella Asiatica as a Treatment</title><title>Journal of experimental pharmacology</title><addtitle>J Exp Pharmacol</addtitle><description>Plant treatment has been used for thousands of years and has been proven to treat acute and chronic diseases. The function of the traditional plant is as an antimicrobial agent, anticancer, antioxidant, and therapeutic gene in healing wounds and inflammation. Lung fibrosis caused by bleomycin can develop into chronic lung disease, which ends in tissue death if not treated immediately. The purpose of this study is to predict and explain the impact of extract on model rats exposed to bleomycin in their lungs as a treatment or anti-fibrinolysis. This research is an analytical study with a randomized in-vivo experimental design divided into 3 groups of 5 male Wistar rats aged 10 weeks. Negative control group (K) with intratracheal induction of bleomycin alone. The positive group was given intratracheal bleomycin 4 mg/kg/BB on days 0 and 21 and added induction at 400 mg (P1) on days 15 to 49. The other positive group was given intratracheal bleomycin 4 mg/kg/BB on days 0 and 21 and added induction at 800 mg (P2) on days 15 to 49. Data were collected according to findings of lung histology analysis of rat samples. In the interalveolar septum group, there was a difference in Masson's Trichrome staining results in groups K and P1 with p&lt;0.05 (p=0.036). However, there was no difference in histopathological staining results in groups K and P2 (p&gt;0.05). The induction of bleomycin 4 mg/kg/BB was proven to cause fibrosis in the lungs of rats, and extract was used as a treatment. Therefore, further research regarding antifibrotic drugs is hoped to reduce fibrotic areas significantly.</description><subject>Bleomycin</subject><subject>Cancer</subject><subject>Care and treatment</subject><subject>centella asiatica</subject><subject>Chronic diseases</subject><subject>Development and progression</subject><subject>Fibrosis</subject><subject>Lung diseases</subject><subject>Original Research</subject><subject>pulmonary fibrosis</subject><subject>treatment</subject><issn>1179-1454</issn><issn>1179-1454</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNptkt-LEzEQxxdRvOO8J99lQRBBWptfm-RJaulp5UDB-hxmk0mbYzc5N9uD--9NbT1aMHlImHzmy8zkW1WvyWxKCZcfvy1_TH_yhimtn1WXhEg9IVzw5yf3i-o657tZWUxrKfjL6oJpxoXU-rJaf-4w9Y82xMkqup1FV9-Edkg55Bqiq8ct1kvv0Y7hASPmXCdfLzCO2HVQz3OAMVioodD1ekAY-_L2qnrhoct4fTyvql83y_Xi6-T2-5fVYn47sYzQUpx0nnpJSWObxjopLJdMcNYI77imEikCKCmcIMI5YKJVKESLSijBuQJ2Va0Oui7BnbkfQg_Do0kQzN9AGjYGhlJfh0YS56y3DS29cNqCokwwaKRyoKHlWLQ-HbTud22PzpY2BujORM9fYtiaTXowhHCmuNBF4f1RYUi_d5hH04ds93OKmHbZMEIInQmqRUHfHtANlNpC9KlI2j1u5ooIqrRo9tT0P1TZDvtgU0QfSvws4d1JwhahG7c5dbsxpJjPwQ8H0JafzgP6pz7JzOx9ZYqvzNFXhX5zOpon9p-L2B9yuMYn</recordid><startdate>20240930</startdate><enddate>20240930</enddate><creator>Soeroso, Noni Novisari</creator><creator>Ichwan, Muhammad</creator><creator>Wahyuni, Arlinda Sari</creator><creator>Mariedina, Causa Trisna</creator><creator>Pakpahan, Yabestin Alfrianus</creator><general>Dove Medical Press Limited</general><general>Dove</general><general>Dove Medical Press</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-2687-4924</orcidid></search><sort><creationdate>20240930</creationdate><title>Bleomycin-Induced Fibrosis and the Effectiveness of Centella Asiatica as a Treatment</title><author>Soeroso, Noni Novisari ; Ichwan, Muhammad ; Wahyuni, Arlinda Sari ; Mariedina, Causa Trisna ; Pakpahan, Yabestin Alfrianus</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3129-17df2f7216c66cd75c47354365fd4927e2eaa875d515dda35b8e55be8585448a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Bleomycin</topic><topic>Cancer</topic><topic>Care and treatment</topic><topic>centella asiatica</topic><topic>Chronic diseases</topic><topic>Development and progression</topic><topic>Fibrosis</topic><topic>Lung diseases</topic><topic>Original Research</topic><topic>pulmonary fibrosis</topic><topic>treatment</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Soeroso, Noni Novisari</creatorcontrib><creatorcontrib>Ichwan, Muhammad</creatorcontrib><creatorcontrib>Wahyuni, Arlinda Sari</creatorcontrib><creatorcontrib>Mariedina, Causa Trisna</creatorcontrib><creatorcontrib>Pakpahan, Yabestin Alfrianus</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Journal of experimental pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Soeroso, Noni Novisari</au><au>Ichwan, Muhammad</au><au>Wahyuni, Arlinda Sari</au><au>Mariedina, Causa Trisna</au><au>Pakpahan, Yabestin Alfrianus</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Bleomycin-Induced Fibrosis and the Effectiveness of Centella Asiatica as a Treatment</atitle><jtitle>Journal of experimental pharmacology</jtitle><addtitle>J Exp Pharmacol</addtitle><date>2024-09-30</date><risdate>2024</risdate><volume>16</volume><spage>311</spage><epage>320</epage><pages>311-320</pages><issn>1179-1454</issn><eissn>1179-1454</eissn><abstract>Plant treatment has been used for thousands of years and has been proven to treat acute and chronic diseases. The function of the traditional plant is as an antimicrobial agent, anticancer, antioxidant, and therapeutic gene in healing wounds and inflammation. Lung fibrosis caused by bleomycin can develop into chronic lung disease, which ends in tissue death if not treated immediately. The purpose of this study is to predict and explain the impact of extract on model rats exposed to bleomycin in their lungs as a treatment or anti-fibrinolysis. This research is an analytical study with a randomized in-vivo experimental design divided into 3 groups of 5 male Wistar rats aged 10 weeks. Negative control group (K) with intratracheal induction of bleomycin alone. The positive group was given intratracheal bleomycin 4 mg/kg/BB on days 0 and 21 and added induction at 400 mg (P1) on days 15 to 49. The other positive group was given intratracheal bleomycin 4 mg/kg/BB on days 0 and 21 and added induction at 800 mg (P2) on days 15 to 49. Data were collected according to findings of lung histology analysis of rat samples. In the interalveolar septum group, there was a difference in Masson's Trichrome staining results in groups K and P1 with p&lt;0.05 (p=0.036). However, there was no difference in histopathological staining results in groups K and P2 (p&gt;0.05). The induction of bleomycin 4 mg/kg/BB was proven to cause fibrosis in the lungs of rats, and extract was used as a treatment. Therefore, further research regarding antifibrotic drugs is hoped to reduce fibrotic areas significantly.</abstract><cop>New Zealand</cop><pub>Dove Medical Press Limited</pub><pmid>39345799</pmid><doi>10.2147/JEP.S463899</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0002-2687-4924</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1179-1454
ispartof Journal of experimental pharmacology, 2024-09, Vol.16, p.311-320
issn 1179-1454
1179-1454
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_71ddcfc62ffe42ba82353a678da9ab4e
source Taylor & Francis Open Access; Publicly Available Content (ProQuest); PubMed Central
subjects Bleomycin
Cancer
Care and treatment
centella asiatica
Chronic diseases
Development and progression
Fibrosis
Lung diseases
Original Research
pulmonary fibrosis
treatment
title Bleomycin-Induced Fibrosis and the Effectiveness of Centella Asiatica as a Treatment
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T21%3A12%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Bleomycin-Induced%20Fibrosis%20and%20the%20Effectiveness%20of%20Centella%20Asiatica%20as%20a%20Treatment&rft.jtitle=Journal%20of%20experimental%20pharmacology&rft.au=Soeroso,%20Noni%20Novisari&rft.date=2024-09-30&rft.volume=16&rft.spage=311&rft.epage=320&rft.pages=311-320&rft.issn=1179-1454&rft.eissn=1179-1454&rft_id=info:doi/10.2147/JEP.S463899&rft_dat=%3Cgale_doaj_%3EA815289565%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3129-17df2f7216c66cd75c47354365fd4927e2eaa875d515dda35b8e55be8585448a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3111205295&rft_id=info:pmid/39345799&rft_galeid=A815289565&rfr_iscdi=true